Related references
Note: Only part of the references are listed.Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
Benjamin H. Mullish et al.
GUT (2019)
Alterations in the relative abundance of Faecalibacterium prausnitzii correlate with changes in fecal calprotectin in patients with ileal Crohn's disease: a longitudinal study
Olle Bjorkqvist et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Fecal Transplant in Children With Clostridioides difficile Gives Sustained Reduction in Antimicrobial Resistance and Potential Pathogen Burden
Suchitra K. Hourigan et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection
Christian Lodberg Hvas et al.
GASTROENTEROLOGY (2019)
Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection
Anna M. Seekatz et al.
ANAEROBE (2018)
Microbial taxonomic and metabolic alterations during faecal microbiota transplantation to treat Clostridium difficile infection
Lee Kellingray et al.
JOURNAL OF INFECTION (2018)
Competitively Selected Donor Fecal Microbiota Transplantation: Butyrate Concentration and Diversity as Measures of Donor Quality
Danielle Barnes et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2018)
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis
Michael Mintz et al.
PLOS ONE (2018)
National Surveillance for Clostridioides difficile Infection, Sweden, 2009-2016
Kristina Rizzardi et al.
EMERGING INFECTIOUS DISEASES (2018)
The association of type II diabetes with gut microbiota composition
Fatemeh Navab-Moghadam et al.
MICROBIAL PATHOGENESIS (2017)
Functional Characterization of Novel Faecalibacterium prausnitzii Strains Isolated from Healthy Volunteers: A Step Forward in the Use of F. prausnitzii as a Next-Generation Probiotic
Rebeca Martin et al.
FRONTIERS IN MICROBIOLOGY (2017)
Profiling Living Bacteria Informs Preparation of Fecal Microbiota Transplantations
Nathaniel D. Chu et al.
PLOS ONE (2017)
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection
M. N. Quraishi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease
E. Quevrain et al.
GUT (2016)
Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa
Hester Eppinga et al.
JOURNAL OF CROHNS & COLITIS (2016)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G. Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Rectal bacteriotherapy for recurrent Clostridium difficile-associated diarrhoea: results from a case series of 55 patients in Denmark 2000-2012
M. Tvede et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Recurrent Clostridium difficile infection is associated with increased mortality
M. A. Olsen et al.
CLINICAL MICROBIOLOGY AND INFECTION (2015)
Burden of Clostridium difficile Infection in the United States
Fernanda C. Lessa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection
S. B. Debast et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
Kathleen Machiels et al.
GUT (2014)
Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection
Susana Fuentes et al.
ISME JOURNAL (2014)
Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Casey M. Theriot et al.
NATURE COMMUNICATIONS (2014)
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent
Laura Wrzosek et al.
BMC BIOLOGY (2013)
Intestinal Dysbiosis and Depletion of Butyrogenic Bacteria in Clostridium difficile Infection and Nosocomial Diarrhea
Vijay C. Antharam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection
Yang Song et al.
PLOS ONE (2013)
Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut
Elaine O. Petrof et al.
MICROBIOME (2013)
Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection
Lawrence J. Brandt et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management
David W. Eyre et al.
CLINICAL INFECTIOUS DISEASES (2012)
Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice
Trevor D. Lawley et al.
PLOS PATHOGENS (2012)
Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children
Giada De Palma et al.
BMC MICROBIOLOGY (2010)
Differential Adaptation of Human Gut Microbiota to Bariatric Surgery-Induced Weight Loss Links With Metabolic and Low-Grade Inflammation Markers
Jean-Pierre Furet et al.
DIABETES (2010)
Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
Alexander Khoruts et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)
Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine
Petra Louis et al.
FEMS MICROBIOLOGY LETTERS (2009)
Twin Studies Reveal Specific Imbalances in the Mucosa-associated Microbiota of Patients with Ileal Crohn's Disease
Ben Willing et al.
INFLAMMATORY BOWEL DISEASES (2009)
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
Harry Sokol et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Enteric salmonellosis disrupts the microbial ecology of the murine gastrointestinal tract
Melissa Barman et al.
INFECTION AND IMMUNITY (2008)
Breaking the cycle:: Treatment strategies for 163 cases of recurrent Clostridium difficile disease
LV McFarland et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Butyrate inhibits inflammatory responses through NF kappa B inhibition: implications for Crohn's disease
JP Segain et al.
GUT (2000)
Share Paper
